Physician Payments from Pharmaceutical Companies Related to Cancer Drugs is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute for Health Care Management Foundation
Grant: GC260700
NIH
Grant: NCI P30CA008748
NIH
Grant: NCI R37CA264563
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R37 CA264563
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R37CA264563-02
Understanding the Importance of Industry Relationships for Cancer Care Quality, Outcomes, and Costs
FWCI
1.37
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals